Annual banned-substance review 16th edition-Analytical approaches in human sports drug testing 2022/2023
- PMID: 37985429
- DOI: 10.1002/dta.3602
Annual banned-substance review 16th edition-Analytical approaches in human sports drug testing 2022/2023
Abstract
In this 16th edition of the annual banned-substance review on analytical approaches in human sports drug testing, literature on recent developments in this particular section of global anti-doping efforts that was published between October 2022 and September 2023 is summarized and discussed. Most recent additions to the continuously growing portfolio of doping control analytical approaches and investigations into analytical challenges in the context of adverse analytical findings are presented, taking into account existing as well as emerging challenges in anti-doping, with specific focus on substances and methods of doping recognized in the World Anti-Doping Agency's 2023 Prohibited List. As in previous years, focus is put particularly on new or enhanced analytical options in human doping controls, appreciating the exigence and core mission of anti-doping and, equally, the conflict arising from the opposingly trending extent of the athlete's exposome and the sensitivity of instruments nowadays commonly available in anti-doping laboratories.
Keywords: anabolics; contamination; doping; exposure; sport.
© 2023 The Authors. Drug Testing and Analysis published by John Wiley & Sons Ltd.
Similar articles
-
Annual Banned-Substance Review 17th Edition-Analytical Approaches in Human Sports Drug Testing 2023/2024.Drug Test Anal. 2025 Aug;17(8):1417-1442. doi: 10.1002/dta.3835. Epub 2024 Dec 28. Drug Test Anal. 2025. PMID: 39731401 Free PMC article. Review.
-
Annual banned-substance review-Analytical approaches in human sports drug testing 2021/2022.Drug Test Anal. 2023 Jan;15(1):5-26. doi: 10.1002/dta.3408. Epub 2022 Nov 22. Drug Test Anal. 2023. PMID: 36369629 Review.
-
Annual banned-substance review: Analytical approaches in human sports drug testing 2020/2021.Drug Test Anal. 2022 Jan;14(1):7-30. doi: 10.1002/dta.3199. Epub 2021 Nov 23. Drug Test Anal. 2022. PMID: 34788500 Review.
-
Annual banned-substance review: Analytical approaches in human sports drug testing 2019/2020.Drug Test Anal. 2021 Jan;13(1):8-35. doi: 10.1002/dta.2969. Epub 2020 Dec 2. Drug Test Anal. 2021. PMID: 33185038 Review.
-
Annual banned-substance review: Analytical approaches in human sports drug testing.Drug Test Anal. 2018 Jan;10(1):9-27. doi: 10.1002/dta.2336. Epub 2017 Dec 18. Drug Test Anal. 2018. PMID: 29149502 Review.
Cited by
-
Administration Route Differentiation of Altrenogest via the Metabolomic LC-HRMS Analysis of Equine Urine.Molecules. 2024 Oct 22;29(21):4988. doi: 10.3390/molecules29214988. Molecules. 2024. PMID: 39519629 Free PMC article.
-
Laboratory medicine and sports: where are we now?Biochem Med (Zagreb). 2024 Oct 15;34(3):030501. doi: 10.11613/BM.2024.030501. Epub 2024 Aug 5. Biochem Med (Zagreb). 2024. PMID: 39171092 Free PMC article. Review.
-
The impact of sample retention and further analysis on doping behavior and detection: evidence from agent-based simulations.Front Sports Act Living. 2025 Jun 18;7:1578929. doi: 10.3389/fspor.2025.1578929. eCollection 2025. Front Sports Act Living. 2025. PMID: 40606274 Free PMC article.
-
Annual Banned-Substance Review 17th Edition-Analytical Approaches in Human Sports Drug Testing 2023/2024.Drug Test Anal. 2025 Aug;17(8):1417-1442. doi: 10.1002/dta.3835. Epub 2024 Dec 28. Drug Test Anal. 2025. PMID: 39731401 Free PMC article. Review.
-
Protein to biomaterials: Unraveling the antiviral and proangiogenic activities of Ac-Tβ1-17 peptide, a thymosin β4 metabolite, and its implications in peptide-scaffold preparation.Bioact Mater. 2025 Mar 19;49:437-455. doi: 10.1016/j.bioactmat.2025.02.008. eCollection 2025 Jul. Bioact Mater. 2025. PMID: 40177110 Free PMC article.
References
REFERENCES
-
- Thevis M, Kuuranne T, Geyer H. Annual banned-substance review-analytical approaches in human sports drug testing 2021/2022. Drug Test Anal. 2023;15(1):5-26. doi:10.1002/dta.3408
-
- Hopker JG, Griffin JE, Hinoveanu LC, Saugy J, Faiss R. Competitive performance as a discriminator of doping status in elite athletes. Drug Test Anal. 2023. doi:10.1002/dta.3563
-
- Lauritzen F, Holden G. Intelligence-based doping control planning improves testing effectiveness: perspectives from a national anti-doping organisation. Drug Test Anal. 2023;15(5):506-515. doi:10.1002/dta.3435
-
- McLean S, Naughton M, Kerherve H, Salmon PM. From anti-doping-I to anti-doping-II: toward a paradigm shift for doping prevention in sport. Int J Drug Policy. 2023;115:104019. doi:10.1016/j.drugpo.2023.104019
-
- Pavot D, Faiss R. Where is the frontier between integrity in sport and anti-doping if it exists? Front Sports Act Living. 2023;5:1158055. doi:10.3389/fspor.2023.1158055
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials